JPS5687567A - Manufacture of molecular compound - Google Patents

Manufacture of molecular compound

Info

Publication number
JPS5687567A
JPS5687567A JP16577880A JP16577880A JPS5687567A JP S5687567 A JPS5687567 A JP S5687567A JP 16577880 A JP16577880 A JP 16577880A JP 16577880 A JP16577880 A JP 16577880A JP S5687567 A JPS5687567 A JP S5687567A
Authority
JP
Japan
Prior art keywords
manufacture
molecular compound
molecular
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16577880A
Other languages
English (en)
Inventor
Bogusuzu Yan
Remiesuzu Rukunai
Rusuzukuzeusukii Ierujii
Pakorujiiku Ierujii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LODZKIE ZAKLADY FARMA
Original Assignee
LODZKIE ZAKLADY FARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LODZKIE ZAKLADY FARMA filed Critical LODZKIE ZAKLADY FARMA
Publication of JPS5687567A publication Critical patent/JPS5687567A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32—Oxygen atoms
    • C07D231/34—Oxygen atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP16577880A 1979-11-26 1980-11-25 Manufacture of molecular compound Pending JPS5687567A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL1979219874A PL122256B1 (en) 1979-11-26 1979-11-26 Process for preparing molecular compound of beta-diethylaminoethylamide of p-chlorophenoxyacetic acid with 4-n-butyl-3,5-diketo-1,2-diphenylpyrazolidin

Publications (1)

Publication Number Publication Date
JPS5687567A true JPS5687567A (en) 1981-07-16

Family

ID=19999619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16577880A Pending JPS5687567A (en) 1979-11-26 1980-11-25 Manufacture of molecular compound

Country Status (8)

Country Link
JP (1) JPS5687567A (ja)
CS (1) CS212286B2 (ja)
DD (1) DD154817A5 (ja)
GB (1) GB2064522B (ja)
HU (1) HU185287B (ja)
PL (1) PL122256B1 (ja)
RO (1) RO81174B (ja)
SU (1) SU1034605A3 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908863A (en) * 1996-02-27 1999-06-01 Dompe' S.P.A. Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203538B (en) * 1988-03-10 1991-08-28 Richter Gedeon Vegyeszet Process for producing 1,2-diphenyl-3,5-dioxy-4-butyl-pirazolidin-sodium-monohydrate
CA3064078A1 (en) 2017-06-13 2018-12-20 Afecta Pharmaceuticals, Inc. Ccl2 inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908863A (en) * 1996-02-27 1999-06-01 Dompe' S.P.A. Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism

Also Published As

Publication number Publication date
PL219874A1 (ja) 1981-06-05
PL122256B1 (en) 1982-07-31
RO81174A (ro) 1983-04-29
GB2064522B (en) 1983-05-11
HU185287B (en) 1984-12-28
RO81174B (ro) 1983-04-30
SU1034605A3 (ru) 1983-08-07
DD154817A5 (de) 1982-04-21
GB2064522A (en) 1981-06-17
CS212286B2 (en) 1982-03-26

Similar Documents

Publication Publication Date Title
JPS5616486A (en) Manufacture of oxoalkylxanthine
JPS55106264A (en) Manufacture of benzimidazolylbenzofurans
JPS5612360A (en) Manufacture of oosubstituteddketoxime
JPS55154968A (en) Manufacture of epsilonncaprolactone
JPS55137115A (en) Manufacture of carboxyllatex
JPS5625153A (en) Manufacture of methylenecycloamines
JPS55105632A (en) Manufacture of etheralcohol
JPS55133361A (en) Manufacture of hydroxyethylazoles
JPS55130966A (en) Manufacture of thiazolidinee22thione
JPS5681565A (en) Manufacture of nnheterocyclic compound
JPS55115890A (en) Manufacture of diorganomagnesium compound
JPS5692278A (en) Manufacture of dibenzazolyl compound
JPS55147285A (en) Novel manufacture of imidazobenzodiazepine
JPS55125156A (en) Manufacture of 11aminoo22phenoxyy44hydroxyyanthraquinone
JPS55104223A (en) Manufacture of alphaahydroxycarbonyl compound
JPS55115885A (en) Manufacture of 33hydroxy compound
JPS5626828A (en) Manufacture of 44fluoroo33phenoxyytoluene
JPS5616419A (en) Manufacture of trifluoromethylnaphthalene
JPS55111464A (en) Manufacture of 77acylindolinee22one
JPS55113789A (en) Manufacture of betaalactam compound
JPS5687567A (en) Manufacture of molecular compound
JPS55167295A (en) Improved manufacture of 3300demethylfortimicins
JPS55160770A (en) Manufacture of hexafluorotriarylisocyanurate
JPS55141473A (en) Manufacture of substituted 22aminopyrazines
JPS56123967A (en) Manufacture of omegaalactam